Induction of cytoprotective autophagy by morusin via AMP-activated protein kinase activation in human non-small cell lung cancer cells.

Published in: Nutrition research and practice (2020)

Our findings suggest that combination treatment with morusin and autophagy inhibitor or AMPK inhibitor might enhance the clinical efficacy of morusin for NSCLC.

Keyphrases

protein kinase
cell death
endoplasmic reticulum stress
endothelial cells
signaling pathway
oxidative stress
small cell lung cancer
single cell
cell therapy
skeletal muscle
induced pluripotent stem cells
stem cells
pluripotent stem cells